Cargando…
Selective immunosuppression by administration of major histocompatibility complex class II-binding peptides. II. Preventive inhibition of primary and secondary in vivo antibody responses
The self-mouse lysozyme peptide corresponding to residues 46-62 (ML46- 62) binds to the major histocompatibility complex (MHC) class II molecules I-A(k) and it selectively inhibits, when coinjected with antigen, priming of I-A(k)-restricted, antigen-specific T cells. We demonstrate that administrati...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2191012/ https://www.ncbi.nlm.nih.gov/pubmed/8478615 |
Ejemplares similares
-
Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation
Publicado: (1992) -
An insulin peptide that binds an alternative site in class II major histocompatibility complex
Publicado: (1996) -
Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II
Publicado: (1995) -
Enhanced binding of peptide antigen to purified class II major histocompatibility glycoproteins at acidic pH
Publicado: (1991) -
Invariant chain cleavage and peptide loading in major histocompatibility complex class II vesicles
Publicado: (1995)